StockData

Can B Corp (NASC) stock

NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)

Close on Oct 19, 2026Market cap $981.54KP/E –Yield –

Can B operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Can B's operating income for the twelve months ending Sep 30, 2024 was -$10.71M. For fiscal 2023 it was -$7.49M. The highest annual figure on record is -$712.79K in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$7.49M–
FY2022Dec 31, 2022-$14.17M–
FY2021Dec 31, 2021-$10.27M–
FY2020Dec 31, 2020-$7.54M–
FY2019Dec 31, 2019-$5.89M–
FY2018Dec 31, 2018-$3.42M–
FY2017Dec 31, 2017-$712.79K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024-$2.83M–
Q2 FY2024Jun 30, 2024-$1.57M–
Q1 FY2024Mar 31, 2024-$5.65M–
Q4 FY2023Dec 31, 2023-$651.72K–
Q3 FY2023Sep 30, 2023-$3.58M–
Q2 FY2023Jun 30, 2023-$1.82M–
Q1 FY2023Mar 31, 2023-$1.43M–
Q4 FY2022Dec 31, 2022-$2.59M–
Q3 FY2022Sep 30, 2022-$6.83M–
Q2 FY2022Jun 30, 2022-$1.56M–
Q1 FY2022Mar 31, 2022-$3.19M–
Q4 FY2021Dec 31, 2021-$3.36M–
Q3 FY2021Sep 30, 2021-$2.52M–
Q2 FY2021Jun 30, 2021-$2.59M–
Q1 FY2021Mar 31, 2021-$1.79M–
Q4 FY2020Dec 31, 2020-$4.53M–
Q3 FY2020Sep 30, 2020-$772.64K–
Q2 FY2020Jun 30, 2020-$1.12M–
Q1 FY2020Mar 31, 2020-$1.11M–
Q4 FY2019Dec 31, 2019-$2.35M–
Q3 FY2019Sep 30, 2019-$935.26K–
Q2 FY2019Jun 30, 2019-$1.44M–
Q1 FY2019Mar 31, 2019-$1.17M–
Q4 FY2018Dec 31, 2018-$1.65M–
Q3 FY2018Sep 30, 2018-$666.91K–
Q2 FY2018Jun 30, 2018-$468.44K–
Q1 FY2018Mar 31, 2018-$634.69K–

More Can B figures

See a number that looks wrong?